Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Validation of an Algorithm for Predicting Hypoglycemia From Continuous Glucose Measurements and Heart Rate Variability Data.

Cichosz SL, Henriksen MM, Tarnow L, Thorsteinsson B, Pedersen-Bjergaard U, Fleischer J.

J Diabetes Sci Technol. 2019 Jul 31:1932296819864625. doi: 10.1177/1932296819864625. [Epub ahead of print] No abstract available.

PMID:
31364406
2.

The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design.

Agesen RM, Alibegovic AC, Andersen HU, Beck-Nielsen H, Gustenhoff P, Hansen TK, Hedetoft C, Jensen T, Juhl CB, Lerche SS, Nørgaard K, Parving HH, Tarnow L, Thorsteinsson B, Pedersen-Bjergaard U.

BMC Endocr Disord. 2019 Jul 23;19(1):78. doi: 10.1186/s12902-019-0408-x.

3.

Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.

Winther SA, Øllgaard JC, Tofte N, Tarnow L, Wang Z, Ahluwalia TS, Jorsal A, Theilade S, Parving HH, Hansen TW, Hazen SL, Pedersen O, Rossing P.

Diabetes Care. 2019 Aug;42(8):1512-1520. doi: 10.2337/dc19-0048. Epub 2019 May 23.

PMID:
31123156
4.

Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes.

Hansen CS, Frandsen CS, Fleischer J, Vistisen D, Holst JJ, Tarnow L, Knop FK, Madsbad S, Andersen HU, Dejgaard TF.

Front Endocrinol (Lausanne). 2019 Apr 12;10:242. doi: 10.3389/fendo.2019.00242. eCollection 2019.

5.

Prediction of In-Hospital Pressure Ulcer Development.

Cichosz SL, Voelsang AB, Tarnow L, Hasenkam JM, Fleischer J.

Adv Wound Care (New Rochelle). 2019 Jan 1;8(1):1-6. doi: 10.1089/wound.2018.0803. Epub 2019 Jan 5.

6.

Intermittent vacuum treatment with VacuMed does not improve peripheral artery disease or walking capacity in patients with intermittent claudication.

Afzelius P, Molsted S, Tarnow L.

Scand J Clin Lab Invest. 2018 Oct;78(6):456-463. doi: 10.1080/00365513.2018.1497803. Epub 2018 Sep 27.

PMID:
30261748
7.

LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial.

Game F, Jeffcoate W, Tarnow L, Jacobsen JL, Whitham DJ, Harrison EF, Ellender SJ, Fitzsimmons D, Löndahl M; LeucoPatch II trial team.

Lancet Diabetes Endocrinol. 2018 Nov;6(11):870-878. doi: 10.1016/S2213-8587(18)30240-7. Epub 2018 Sep 19.

PMID:
30243803
8.

Carotid intima media thickness and ankle brachial index are inversely associated in subjects with and without diabetes.

Winckler K, Wiinberg N, Jensen AK, Thorsteinsson B, Lundby-Christensen L, Heitmann BL, Jensen GB, Tarnow L.

Scand J Clin Lab Invest. 2018 Oct;78(6):464-469. doi: 10.1080/00365513.2018.1499124. Epub 2018 Aug 3.

PMID:
30073874
9.

The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial.

Dhatariya K, Bain SC, Buse JB, Simpson R, Tarnow L, Kaltoft MS, Stellfeld M, Tornøe K, Pratley RE; LEADER Publication Committee on behalf of the LEADER Trial Investigators.

Diabetes Care. 2018 Oct;41(10):2229-2235. doi: 10.2337/dc18-1094. Epub 2018 Aug 2.

PMID:
30072400
10.

The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial.

Nordklint AK, Almdal TP, Vestergaard P, Lundby-Christensen L, Boesgaard TW, Breum L, Gade-Rasmussen B, Sneppen SB, Gluud C, Hemmingsen B, Jensen T, Krarup T, Madsbad S, Mathiesen ER, Perrild H, Tarnow L, Thorsteinsson B, Vestergaard H, Lund SS, Eiken P.

Osteoporos Int. 2018 Nov;29(11):2517-2526. doi: 10.1007/s00198-018-4637-z. Epub 2018 Jul 19.

PMID:
30027438
11.

Arterial stiffness in people with Type 2 diabetes and obstructive sleep apnoea.

Hvelplund Kristiansen M, Banghøj AM, Laugesen E, Tarnow L.

Diabet Med. 2018 Oct;35(10):1391-1398. doi: 10.1111/dme.13666. Epub 2018 May 24.

PMID:
29763980
12.

Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.

Agesen RM, Kristensen PL, Beck-Nielsen H, Nørgaard K, Perrild H, Jensen T, Parving HH, Thorsteinsson B, Tarnow L, Pedersen-Bjergaard U.

Diabetes Technol Ther. 2018 Mar;20(3):247-256. doi: 10.1089/dia.2017.0372. Epub 2018 Mar 12.

PMID:
29565719
13.

Reduced Inspiratory Muscle Strength in Patients with Type 2 Diabetes Mellitus and Obstructive Sleep Apnoea.

Rehling T, Banghøj AM, Kristiansen MH, Tarnow L, Molsted S.

J Diabetes Res. 2017;2017:4121794. doi: 10.1155/2017/4121794. Epub 2017 Sep 25.

14.

Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies.

Peeters SA, Engelen L, Buijs J, Chaturvedi N, Fuller JH, Jorsal A, Parving HH, Tarnow L, Theilade S, Rossing P, Schalkwijk CG, Stehouwer CDA.

Cardiovasc Diabetol. 2017 Oct 25;16(1):139. doi: 10.1186/s12933-017-0620-9.

15.

The LeucoPatch® system in the management of hard-to-heal diabetic foot ulcers: study protocol for a randomised controlled trial.

Game F, Jeffcoate W, Tarnow L, Day F, Fitzsimmons D, Jacobsen J.

Trials. 2017 Oct 10;18(1):469. doi: 10.1186/s13063-017-2216-9.

16.

Effect of liraglutide on myocardial glucose uptake and blood flow in stable chronic heart failure patients: A double-blind, randomized, placebo-controlled LIVE sub-study.

Nielsen R, Jorsal A, Iversen P, Tolbod LP, Bouchelouche K, Sørensen J, Harms HJ, Flyvbjerg A, Tarnow L, Kistorp C, Gustafsson I, Bøtker HE, Wiggers H.

J Nucl Cardiol. 2019 Apr;26(2):585-597. doi: 10.1007/s12350-017-1000-2. Epub 2017 Aug 2.

PMID:
28770459
17.

Continuous glucose monitoring adds information beyond HbA1c in well-controlled diabetes patients with early cardiovascular autonomic neuropathy.

Fleischer J, Laugesen E, Cichosz SL, Hoeyem P, Dejgaard TF, Poulsen PL, Tarnow L, Hansen TK.

J Diabetes Complications. 2017 Sep;31(9):1389-1393. doi: 10.1016/j.jdiacomp.2017.06.013. Epub 2017 Jun 30.

PMID:
28728915
18.

Readmission to hospital of medical patients - A cohort study.

Rasmussen MG, Ravn P, Molsted S, Tarnow L, Rosthøj S.

Eur J Intern Med. 2017 Dec;46:19-24. doi: 10.1016/j.ejim.2017.07.008. Epub 2017 Jul 16.

PMID:
28724505
19.

Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.

Galsgaard J, Persson F, Hansen TW, Jorsal A, Tarnow L, Parving HH, Rossing P.

Kidney Int. 2017 Nov;92(5):1242-1248. doi: 10.1016/j.kint.2017.04.018. Epub 2017 Jul 14.

PMID:
28712855
20.

Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease in Individuals With Type 1 Diabetes: A 12-Year Follow-up Study.

Hanssen NMJ, Scheijen JLJM, Jorsal A, Parving HH, Tarnow L, Rossing P, Stehouwer CDA, Schalkwijk CG.

Diabetes. 2017 Aug;66(8):2278-2283. doi: 10.2337/db16-1578. Epub 2017 Jun 6.

21.

Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.

Peeters SA, Engelen L, Buijs J, Jorsal A, Parving HH, Tarnow L, Rossing P, Schalkwijk CG, Stehouwer CDA.

Cardiovasc Diabetol. 2017 Apr 26;16(1):55. doi: 10.1186/s12933-017-0539-1.

22.

Incident microalbuminuria and complement factor mannan-binding lectin-associated protein 19 in people with newly diagnosed type 1 diabetes.

Østergaard JA, Thiel S, Hoffmann-Petersen IT, Hovind P, Parving HH, Tarnow L, Rossing P, Hansen TK.

Diabetes Metab Res Rev. 2017 Jul;33(5). doi: 10.1002/dmrr.2895. Epub 2017 Apr 11.

PMID:
28303635
23.

Are Changes in Heart Rate Variability During Hypoglycemia Confounded by the Presence of Cardiovascular Autonomic Neuropathy in Patients with Diabetes?

Cichosz SL, Frystyk J, Tarnow L, Fleischer J.

Diabetes Technol Ther. 2017 Feb;19(2):91-95. doi: 10.1089/dia.2016.0342.

PMID:
28118049
24.

Hypoglycemia-Associated EEG Changes Following Antecedent Hypoglycemia in Type 1 Diabetes Mellitus.

Sejling AS, Kjaer TW, Pedersen-Bjergaard U, Remvig LS, Frandsen CS, Hilsted L, Faber J, Holst JJ, Tarnow L, Møller JS, Nielsen MN, Thorsteinsson B, Juhl CB.

Diabetes Technol Ther. 2017 Feb;19(2):85-90. doi: 10.1089/dia.2016.0331.

PMID:
28118048
25.

Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with Type 1 diabetes.

Kristensen PL, Tarnow L, Bay C, Nørgaard K, Jensen T, Parving HH, Perrild H, Beck-Nielsen H, Christiansen JS, Thorsteinsson B, Pedersen-Bjergaard U.

Diabet Med. 2017 May;34(5):625-631. doi: 10.1111/dme.13317. Epub 2017 Feb 14.

PMID:
28099755
26.

Higher Parathyroid Hormone Level Is Associated With Increased Arterial Stiffness in Type 1 Diabetes.

Zobel EH, Theilade S, von Scholten BJ, Persson F, Tarnow L, Lajer M, Hansen TW, Rossing P.

Diabetes Care. 2017 Mar;40(3):e32-e33. doi: 10.2337/dc16-2428. Epub 2017 Jan 6. No abstract available.

PMID:
28062524
27.

Obstructive sleep apnoea is frequent in patients with type 1 diabetes.

Banghoej AM, Nerild HH, Kristensen PL, Pedersen-Bjergaard U, Fleischer J, Jensen AE, Laub M, Thorsteinsson B, Tarnow L.

J Diabetes Complications. 2017 Jan;31(1):156-161. doi: 10.1016/j.jdiacomp.2016.10.006. Epub 2016 Oct 14.

PMID:
28029582
28.

The potential for improvement of outcomes by personalized insulin treatment of type 1 diabetes as assessed by analysis of single-patient data from a randomized controlled cross-over insulin trial.

Pedersen-Bjergaard U, Kristensen PL, Beck-Nielsen H, Nørgaard K, Perrild H, Christiansen JS, Jensen T, Parving HH, Thorsteinsson B, Tarnow L.

Diabetes Res Clin Pract. 2017 Jan;123:143-148. doi: 10.1016/j.diabres.2016.11.003. Epub 2016 Nov 16.

PMID:
28012403
29.

Effects of liraglutide on cardiovascular risk factors in patients with type 1 diabetes.

Dejgaard TF, Johansen NB, Frandsen CS, Asmar A, Tarnow L, Knop FK, Madsbad S, Andersen HU.

Diabetes Obes Metab. 2017 May;19(5):734-738. doi: 10.1111/dom.12841. Epub 2017 Jan 19.

PMID:
27935240
30.

Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.

Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hänselmann A, Nilsson B, Møller JE, Hjort J, Rasmussen J, Boesgaard TW, Schou M, Videbaek L, Gustafsson I, Flyvbjerg A, Wiggers H, Tarnow L.

Eur J Heart Fail. 2017 Jan;19(1):69-77. doi: 10.1002/ejhf.657. Epub 2016 Oct 28.

31.

High osteoprotegerin is associated with development of foot ulcer in type 1 diabetes.

Zobel EH, von Scholten BJ, Lajer M, Jorsal A, Tarnow L, Rasmussen LM, Holstein P, Parving HH, Hansen TW, Rossing P.

J Diabetes Complications. 2016 Nov - Dec;30(8):1603-1608. doi: 10.1016/j.jdiacomp.2016.07.008. Epub 2016 Jul 17.

PMID:
27469295
32.

Short-term cost-effectiveness of insulin detemir and insulin aspart in people with type 1 diabetes who are prone to recurrent severe hypoglycemia.

Pedersen-Bjergaard U, Kristensen PL, Nørgaard K, Perrild H, Jensen T, Thorsteinsson B, Nikolajsen A, Tarnow L.

Curr Med Res Opin. 2016 Oct;32(10):1719-1725. doi: 10.1080/03007995.2016.1205006. Epub 2016 Jul 20.

PMID:
27326862
33.

Prediction of excessive weight gain in insulin treated patients with type 2 diabetes.

Cichosz SL, Lundby-Christensen L, Johansen MD, Tarnow L, Almdal TP, Hejlesen OK; The CIMT Trial Group.

J Diabetes. 2017 Apr;9(4):325-331. doi: 10.1111/1753-0407.12418. Epub 2016 Jul 20.

PMID:
27130075
34.

Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial.

Agesen RM, Kristensen PL, Beck-Nielsen H, Nørgaard K, Perrild H, Christiansen JS, Jensen T, Hougaard P, Parving HH, Thorsteinsson B, Tarnow L, Pedersen-Bjergaard U.

Diabetes Metab. 2016 Sep;42(4):249-55. doi: 10.1016/j.diabet.2016.03.001. Epub 2016 Apr 7.

PMID:
27068361
35.

Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial.

Lundby-Christensen L, Vaag A, Tarnow L, Almdal TP, Lund SS, Wetterslev J, Gluud C, Boesgaard TW, Wiinberg N, Perrild H, Krarup T, Snorgaard O, Gade-Rasmussen B, Thorsteinsson B, Røder M, Mathiesen ER, Jensen T, Vestergaard H, Hedetoft C, Breum L, Duun E, Sneppen SB, Pedersen O, Hemmingsen B, Carstensen B, Madsbad S.

BMJ Open. 2016 Feb 25;6(2):e008377. doi: 10.1136/bmjopen-2015-008377.

36.

Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus-the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial.

Lundby-Christensen L, Tarnow L, Boesgaard TW, Lund SS, Wiinberg N, Perrild H, Krarup T, Snorgaard O, Gade-Rasmussen B, Thorsteinsson B, Røder M, Mathiesen ER, Jensen T, Vestergaard H, Hedetoft C, Breum L, Duun E, Sneppen SB, Pedersen O, Hemmingsen B, Carstensen B, Madsbad S, Gluud C, Wetterslev J, Vaag A, Almdal TP.

BMJ Open. 2016 Feb 25;6(2):e008376. doi: 10.1136/bmjopen-2015-008376.

37.

Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.

Dejgaard TF, Frandsen CS, Hansen TS, Almdal T, Urhammer S, Pedersen-Bjergaard U, Jensen T, Jensen AK, Holst JJ, Tarnow L, Knop FK, Madsbad S, Andersen HU.

Lancet Diabetes Endocrinol. 2016 Mar;4(3):221-232. doi: 10.1016/S2213-8587(15)00436-2. Epub 2015 Dec 3.

PMID:
26656289
38.

Erratum. Glycemic Variability Is Associated With Reduced Cardiac Autonomic Modulation in Women With Type 2 Diabetes. Diabetes Care 2015;38:682-688.

Fleischer J, Lebech Cichosz S, Hoeyem P, Laugesen E, Loegstrup Poulsen P, Sandahl Christiansen J, Tarnow L, Krarup Hansen T.

Diabetes Care. 2015 Nov;38(11):2188. doi: 10.2337/dc15-er11. No abstract available.

PMID:
26494810
39.

Glucose-Dependent Insulinotropic Polypeptide Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB.

Berglund LM, Lyssenko V, Ladenvall C, Kotova O, Edsfeldt A, Pilgaard K, Alkayyali S, Brøns C, Forsblom C, Jonsson A, Zetterqvist AV, Nitulescu M, McDavitt CR, Dunér P, Stancáková A, Kuusisto J, Ahlqvist E, Lajer M, Tarnow L, Madsbad S, Rossing P, Kieffer TJ, Melander O, Orho-Melander M, Nilsson P, Groop PH, Vaag A, Lindblad B, Gottsäter A, Laakso M, Goncalves I, Groop L, Gomez MF.

Diabetes. 2016 Jan;65(1):239-54. doi: 10.2337/db15-0122. Epub 2015 Sep 22.

40.

Increased all-cause mortality in patients with type 1 diabetes and high-expression mannan-binding lectin genotypes: a 12-year follow-up study.

Østergaard JA, Thiel S, Lajer M, Steffensen R, Parving HH, Flyvbjerg A, Rossing P, Tarnow L, Hansen TK.

Diabetes Care. 2015 Oct;38(10):1898-903. doi: 10.2337/dc15-0851. Epub 2015 Jul 15.

PMID:
26180106
41.

Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular Dysfunction.

Gerritsen KG, Leeuwis JW, Koeners MP, Bakker SJ, van Oeveren W, Aten J, Tarnow L, Rossing P, Wetzels JF, Joles JA, Kok RJ, Goldschmeding R, Nguyen TQ.

J Diabetes Res. 2015;2015:539787. doi: 10.1155/2015/539787. Epub 2015 Jun 15.

42.

Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci.

Nexø BA, Villesen P, Nissen KK, Lindegaard HM, Rossing P, Petersen T, Tarnow L, Hansen B, Lorenzen T, Hørslev-Petersen K, Jensen SB, Bahrami S, Lajer M, Schmidt KL, Parving HH, Junker P, Laska MJ.

Immunol Res. 2016 Feb;64(1):55-63. doi: 10.1007/s12026-015-8671-z.

43.

Effect of Continuous Glucose Monitoring Accuracy on Clinicians' Retrospective Decision Making in Diabetes: A Pilot Study.

Mahmoudi Z, Johansen MD, Nørgaard HH, Andersen S, Pedersen-Bjergaard U, Tarnow L, Christiansen JS, Hejlesen O.

J Diabetes Sci Technol. 2015 Jun 8;9(5):1092-102. doi: 10.1177/1932296815587935.

44.

IGFBP-4 Fragments as Markers of Cardiovascular Mortality in Type 1 Diabetes Patients With and Without Nephropathy.

Hjortebjerg R, Tarnow L, Jorsal A, Parving HH, Rossing P, Bjerre M, Frystyk J.

J Clin Endocrinol Metab. 2015 Aug;100(8):3032-40. doi: 10.1210/jc.2015-2196. Epub 2015 Jun 5.

PMID:
26046968
45.

Infrared thermographic assessment of changes in skin temperature during hypoglycaemia in patients with type 1 diabetes.

Sejling AS, Lange KH, Frandsen CS, Diemar SS, Tarnow L, Faber J, Holst JJ, Hartmann B, Hilsted L, Kjaer TW, Juhl CB, Thorsteinsson B, Pedersen-Bjergaard U.

Diabetologia. 2015 Aug;58(8):1898-906. doi: 10.1007/s00125-015-3616-6. Epub 2015 May 19.

PMID:
25985748
46.

Vitamin D, carotid intima-media thickness and bone structure in patients with type 2 diabetes.

Winckler K, Tarnow L, Lundby-Christensen L, Almdal TP, Wiinberg N, Eiken P, Boesgaard TW; CIMT trial group.

Endocr Connect. 2015 Jun;4(2):128-35. doi: 10.1530/EC-15-0034. Epub 2015 May 8.

47.

Use of an autologous leucocyte and platelet-rich fibrin patch on hard-to-heal DFUs: a pilot study.

Löndahl M, Tarnow L, Karlsmark T, Lundquist R, Nielsen AM, Michelsen M, Nilsson A, Zakrzewski M, Jörgensen B.

J Wound Care. 2015 Apr;24(4):172-4, 176-8. doi: 10.12968/jowc.2015.24.4.172.

PMID:
25853474
48.

Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study.

Dejgaard TF, Knop FK, Tarnow L, Frandsen CS, Hansen TS, Almdal T, Holst JJ, Madsbad S, Andersen HU.

BMJ Open. 2015 Apr 2;5(4):e007791. doi: 10.1136/bmjopen-2015-007791.

49.

Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes.

Swan EJ, Salem RM, Sandholm N, Tarnow L, Rossing P, Lajer M, Groop PH, Maxwell AP, McKnight AJ; GENIE Consortium.

Diabet Med. 2015 Aug;32(8):1104-9. doi: 10.1111/dme.12763. Epub 2015 Apr 13.

50.

The degree of autonomic modulation is associated with the severity of microvascular complications in patients with type 1 diabetes.

Fleischer J, Cichosz SL, Jakobsen PE, Yderstraede K, Gulichsen E, Nygaard H, Eldrup E, Lervang HH, Tarnow L, Ejskjaer N.

J Diabetes Sci Technol. 2015 May;9(3):681-6. doi: 10.1177/1932296814567226. Epub 2015 Jan 14.

Supplemental Content

Loading ...
Support Center